Clinical trials
Phase 3 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,149 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 18 |
| 2001 | 33 |
| 2002 | 37 |
| 2003 | 33 |
| 2004 | 47 |
| 2005 | 39 |
| 2006 | 53 |
| 2007 | 40 |
| 2008 | 50 |
| 2009 | 47 |
| 2010 | 31 |
| 2011 | 29 |
| 2012 | 34 |
| 2013 | 39 |
| 2014 | 39 |
| 2015 | 36 |
| 2016 | 34 |
| 2017 | 31 |
| 2018 | 31 |
| 2019 | 33 |
| 2020 | 27 |
| 2021 | 46 |
| 2022 | 43 |
| 2023 | 42 |
| 2024 | 37 |
| 2025 | 59 |
| 2026 | 42 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 596 |
| Unknown status | 144 |
| Recruiting | 134 |
| Active, not recruiting | 113 |
| Terminated | 90 |
| Not yet recruiting | 43 |
| Withdrawn | 25 |
| Suspended | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 52 |
| AstraZeneca | 40 |
| Fudan University | 38 |
| Novartis Pharmaceuticals | 38 |
| Alliance for Clinical Trials in Oncology | 36 |
| Pfizer | 21 |
| SWOG Cancer Research Network | 20 |
| National Cancer Institute (NCI) | 19 |
| ETOP IBCSG Partners Foundation | 16 |
| Eli Lilly and Company | 16 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 1,149 |
| Neoplasm Metastasis | 64 |
| Neoplasms | 40 |
| Triple Negative Breast Neoplasms | 33 |
| Breast Neoplasms, Male | 19 |
| Prostatic Neoplasms | 19 |
| Neutropenia | 18 |
| Carcinoma, Intraductal, Noninfiltrating | 16 |
| Hot Flashes | 15 |
| Brain Neoplasms | 14 |
Trials
Showing 1 to 25 of 1,149. Each trial links to its page on Pharma Observatory.
1,049 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.